Skip to main content
SpringerLink
Log in

In Vivo NMR Measures of NAA and the Neurobiology of Schizophrenia

  • Conference paper
N-Acetylaspartate

Part of the book series: Advances in Experimental Medicine and Biology ((volume 576))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

6. References

  1. Weinberger DR, Laruelle M: Neurochemical and neuropharmacologic imaging in schizophrenia, in Neuropsychopharmacology: The Fifth Generation of Progress. Edited by Davis KL, Charney D, Coyle JT, Nemeroff C. Philadelphia, PA, Lippincott Williams & Wilkins, 2002, pp 833–855

    Google Scholar 

  2. Bertolino A, Weinberger DR: Proton magnetic resonance spectroscopy in schizophrenia. Eur J Radiol 1999; 30(2):132–41

    Article  PubMed  CAS  Google Scholar 

  3. Marenco S, Bertolino A, Weinberger DR: MR proton spectroscopy, in Schizophrenia: from neuroimaging to neuroscience, vol 1. Edited by Lawrie SM, Johnstone EC, Weinberger DR. Oxford, UK, Oxford University Press, 2004, pp 73–92

    Google Scholar 

  4. Keshavan MS, Stanley JA, Pettegrew JW: Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part II. Biol Psychiatry 2000; 48(5):369–80

    Article  PubMed  CAS  Google Scholar 

  5. Stanley JA, Pettegrew JW, Keshavan MS: Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part I. Biol Psychiatry 2000; 48(5):357–68

    Article  PubMed  CAS  Google Scholar 

  6. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT: Multisection proton MR spectroscopic imaging of the brain. Radiology 1993; 188(1):277–82

    PubMed  CAS  Google Scholar 

  7. van Der Veen JW, Weinberger DR, Tedeschi G, Frank JA, Duyn JH: Proton MR spectroscopic imaging without water suppression. Radiology 2000; 217(1):296–300

    Google Scholar 

  8. Weinberger DR: Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999; 45(4):395–402

    Article  PubMed  CAS  Google Scholar 

  9. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK, Berman KF, Goldberg TE: Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001; 50(11):825–44

    Article  PubMed  CAS  Google Scholar 

  10. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR: Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996; 153(12):1554–63

    PubMed  CAS  Google Scholar 

  11. Bertolino A, Callicott JH, Nawroz S, Mattay VS, Duyn JH, Tedeschi G, Frank JA, Weinberger DR: Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology 1998; 18(1):1–9

    Article  PubMed  CAS  Google Scholar 

  12. Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, Barnett IS, Duyn JH, Frank JA, Rapoport JL, Weinberger DR: Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1998; 155(10):1376–83

    PubMed  CAS  Google Scholar 

  13. Callicott JH, Egan MF, Bertolino A, Mattay VS, Langheim FJ, Frank JA, Weinberger DR: Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype. Biol Psychiatry 1998; 44(10):941–50

    Article  PubMed  CAS  Google Scholar 

  14. Callicott JH, Bertolino A, Egan MF, Mattay VS, Langheim FJ, Weinberger DR: Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. Am J Psychiatry 2000; 157(10):1646–51

    Article  PubMed  CAS  Google Scholar 

  15. Lewis DA, Lieberman JA: Catching up on schizophrenia: natural history and neurobiology. Neuron 2000; 28(2):325–34

    Article  PubMed  CAS  Google Scholar 

  16. Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, Weinberger DR: The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 2001; 49(1):39–46

    Article  PubMed  CAS  Google Scholar 

  17. Bertolino A, Esposito G, Callicott JH, Mattay VS, Van Horn JD, Frank JA, Berman KF, Weinberger DR: Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry 2000; 157(1):26–33

    PubMed  CAS  Google Scholar 

  18. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, Goldberg TE, Weinberger DR: Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex 2000; 10(11):1078–92

    Article  PubMed  CAS  Google Scholar 

  19. Winterer G, Weinberger DR: Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 2004; 27(11):683–90

    Article  PubMed  CAS  Google Scholar 

  20. Bertolino A, Breier A, Callicott JH, Adler C, Mattay VS, Shapiro M, Frank JA, Pickar D, Weinberger DR: The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology 2000; 22(2):125–32

    Article  PubMed  CAS  Google Scholar 

  21. Bertolino A, Knable MB, Saunders RC, Callicott JH, Kolachana B, Mattay VS, Bachevalier J, Frank JA, Egan M, Weinberger DR: The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry 1999; 45(6):660–7

    Article  PubMed  CAS  Google Scholar 

  22. Lipska BK, Jaskiw GE, Weinberger DR: Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 1993; 9(1):67–75

    PubMed  CAS  Google Scholar 

  23. Saunders RC, Kolachana BS, Bachevalier J, Weinberger DR: Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature 1998; 393(6681):169–71

    Article  PubMed  CAS  Google Scholar 

  24. Lipska BK, Weinberger DR: To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000; 23(3):223–39

    Article  PubMed  CAS  Google Scholar 

  25. Bertolino A, Roffman JL, Lipska BK, van Gelderen P, Olson A, Weinberger DR: Reduced N-acetylaspartate in prefrontal cortex of adult rats with neonatal hippocampal damage. Cereb Cortex 2002; 12(9):983–90

    Article  PubMed  Google Scholar 

  26. Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR: Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. Cereb Cortex 1997; 7(8):740–8

    Article  PubMed  CAS  Google Scholar 

  27. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR: The BDNF val66met polymorphism affects activitydependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112(2):257–69

    Article  PubMed  CAS  Google Scholar 

  28. Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR: Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc Natl Acad Sci U S A 2004; 101(34):12604–9

    Article  PubMed  CAS  Google Scholar 

  29. Steele SU, Marenco S, Barnett AS, van der Veen JW, Egan MF, Weinberger DR: GRM3 genotype is associated with reduced N-acetyl aspartate levels in the frontal cortex: A partial replication. Biological Psychiatry 2004; 55:167S–167S

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genes, Cognition and Psychosis Program, Division of Intramural Research, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA

    Daniel R. Weinberger

Authors
  1. Stefano Marenco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessandro Bertolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel R. Weinberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel R. Weinberger .

Editor information

Editors and Affiliations

  1. Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA

    John R. Moffett  & Aryan M. A. Namboodiri  & 

  2. University of Albany, Albany, NY, 12222, USA

    Suzannah B. Tieman

  3. National Institute of Mental Health, Bethesda, MD, 20814, USA

    Daniel R. Weinberger

  4. McLean Hospital, Belmont, MA, 02178, USA

    Joseph T. Coyle

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this paper

Cite this paper

Marenco, S., Bertolino, A., Weinberger, D.R. (2006). In Vivo NMR Measures of NAA and the Neurobiology of Schizophrenia. In: Moffett, J.R., Tieman, S.B., Weinberger, D.R., Coyle, J.T., Namboodiri, A.M.A. (eds) N-Acetylaspartate. Advances in Experimental Medicine and Biology, vol 576. Springer, Boston, MA . https://doi.org/10.1007/0-387-30172-0_16

Download citation

Publish with us

Policies and ethics

Search

Navigation